Plasma N-terminal tau fragment levels predict future cognitive decline and neurodegeneration in healthy elderly individuals

The availability of blood-based assays detecting Alzheimer’s disease (AD) pathology should greatly accelerate AD therapeutic development and improve clinical care. This is especially true for markers that capture the risk of decline in pre-symptomatic stages of AD, as this would allow one to focus i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chhatwal, Jasmeer P., Schultz, Aaron P., Dang, Yifan, Ostaszewski, Beth, Liu, Lei, Yang, Hyun-Sik, Johnson, Keith A., Sperling, Reisa A., Selkoe, Dennis J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695712/
https://www.ncbi.nlm.nih.gov/pubmed/33247134
http://dx.doi.org/10.1038/s41467-020-19543-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695712/
https://www.ncbi.nlm.nih.gov/pubmed/33247134
http://dx.doi.org/10.1038/s41467-020-19543-w

Ejemplares similares